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Respiratory diseases, including inflammatory airway disease (IAD), viral and bacterial infections, are common problems
in exercising horses. The airway epithelium constitutes a major physical barrier against airborne infections and plays an
essential role in the lung innate immune response mainly through toll-like receptor (TLR) activation. The aim of this
study was to develop a model for the culture of equine bronchial epithelial cells (EBEC) in vitro and to explore EBEC
innate immune responses in trained horses. Bronchial epithelial biopsies were taken from 6 adult horses during lower
airway endoscopy. EBEC were grown in vitro by an explant method. The innate immune response of EBEC was
evaluated in vitro by treatment with TLR ligands. TLR3 is the most strongly expressed TLR at the mRNA level in
EBEC and stimulation of EBEC with Poly(I:C), an analog of viral dsRNA, triggers a strong secretion of IFN-β, TNF-α,
IL-6 and CXCL8. We further evaluated the EBEC innate immune response in horses that underwent a 4-month-
training program. While training had no effect on TLR mRNA expression in EBEC as well as in bronchial biopsies,
it increased the production of IFN-β after stimulation with a TLR3 ligand and decreased the secretion of TNF-α
and IL-6 after stimulation with a TLR2 and TLR3 ligand. These findings may be implicated in the increased risk for
viral and bacterial infections observed in sport horses. Altogether, we report a successful model for the culture of
EBEC that can be applied to the investigation of pathophysiologic conditions in longitudinal studies.Introduction
Respiratory diseases represent the second most common
disorder requiring veterinary medical attention in adult
horses [1]. They are also the second most common ailment
in young racehorses [2,3] and result in huge economic
losses to the racing industry. Both viral and bacterial infec-
tions as well as inflammatory conditions, such as Inflamma-
tory Airway Disease (IAD), are mainly responsible for those
respiratory diseases. Young horses are more susceptible to
viral infection than older horses [4] and exercise potentiates
this risk for viral infection [4,5]. Bacterial infections can
occur as a primary disease or secondary to viral infections.
IAD is a frequent problem in young sports horses, espe-
cially racehorses. Its prevalence varies from 7 to 70% de-
pending on the geographic region and the horse population
studied [6-9]. It is most frequently observed in 2 year olds
[2,7,10-12] and has been associated with viral and/or bac-
terial infections [7,10-12]. The underlying pathophysiology* Correspondence: linda.frellstedt@ulg.ac.be
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unless otherwise stated.of these respiratory diseases, especially the involvement of
innate and adaptive immune mechanisms, is currently not
well understood. However, intensive training has been
reported to alter the innate immune response in the lung
and the systemic circulation [13]. We have recently demon-
strated that TLR3 mRNA expression as well as TNF-α and
IFN-β production were down-regulated in equine pulmo-
nary alveolar macrophages (PAM) from trained horses.
On the contrary, TLR4 mRNA expression and cytokine
secretion were amplified in blood monocytes.
The lung innate immune defense against pathogens also
implicates the airway epithelium which strongly interacts
with other resident cells and leukocytes. Indeed, the air-
way epithelium plays an essential role [14,15] firstly as a
physical barrier between the external environment and
the host [15,16] and secondly by modulating the in-
flammatory reaction and the response to pathogens
[17]. The ciliated airway epithelium prevents colonization
by inhaled bacteria through their physical removal by ciliary
clearance and cough, through the presence of antimicrobial
proteins in the mucus and through the recruitment ofal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gen recognition receptors (PRR), located on the surface or
in intracellular compartments, interact with pathogen-
associated molecular patterns (PAMP) and control the host
defense mechanisms. Toll-like receptors (TLR) represent
important signaling PRR that recognize PAMP [18,19].
TLR2 heterodimerizes with TLR1 or TLR6; TLR1/2 and
TLR2/6 recognize molecular pattern specific for gram-
positive bacteria. TLR3 mediates the response to double-
stranded RNA, a marker of viral infection. TLR4 recognizes
bacterial lipopolysaccharide (LPS) specific for gram-
negative bacteria. TLR5 responds to flagellin which can be
found on flagellated bacteria. TLR7/8 recognizes viral
single-stranded RNA. Finally, TLR9 mediates the response
to unmethylated DNA (CpG) which can be part of bacteria
or viruses [18,19]. Once TLR are stimulated by PAMP, a
downstream cascade is activated which results in the pro-
duction of interferons (IFN), pro-inflammatory cytokines,
chemokines, and cytotoxic activities [18,19]. Type I inter-
ferons are central to the early antiviral response of virus-
infected cells [15] and interfere with viral replication,
protein synthesis as well as early cell apoptosis. Activation
of TLR is essential for an immediate protection against viral
and bacterial infection. Epithelial cells express a large array
of TLR and their activation leads to the secretion of a var-
iety of cytokines (IFN, IL-6, TNF-α) and chemokines
(CXCL8) [16]. CXCL8 is an essential chemotactic factor
for neutrophils and its production is associated with
viral, bacterial and fungal infections [16]. The mucosal
response, including the innate response, aims to clear
the sensed pathogens and to control secondary effects
associated with neutrophils and their products [14].
Altogether, this underlines that TLR activation in the
airway epithelium is important in order to tightly con-
trol the intensity and duration of this response in favor
of preventing respiratory lesions [14].
In the interest of defining the physiopathologic role of
bronchial epithelial cells in respiratory diseases in horses,
ex vivo approaches are needed as previously reported in
humans [20]. Few reports describe the use of bronchial
epithelial cell culture in horses [21-27] and even fewer
have used this technique for the study of equine diseases
[21,22,27]. In order to perform this kind of study, we de-
veloped a method of culture for equine bronchial epithe-
lial cells (EBEC) using bronchial biopsies collected from
living animals. This method offers the possibility to per-
form repeated sampling. After the development phase of
this protocol, we were able to obtain EBEC responsive to
TLR ligands similarly to the airway epithelium, at least
when considering the innate immune response. Based on
this method, we analyzed the impact of intense training
and acute exercise on the expression and function of TLR
in EBEC to identify their role in equine respiratory dis-
eases. Our results demonstrate that the expression ofthese receptors was not modified although the production
of some cytokines in response to TLR ligands was altered.
Using this new culture method, we were able to demon-
strate some alteration in the function of EBEC in horses
submitted to intense training.Materials and methods
Horses
Six healthy Standardbred horses (3 mares and 3 geld-
ings, 3 to 6 years old, 495.3 ± 55.2 kg) were used for the
first part of the study to develop optimal EBEC culture
conditions and EBEC responsiveness in vitro. All horses
were determined to be healthy by physical examination,
complete blood cell count, serum biochemistry, endo-
scopic evaluation of the respiratory tract and examin-
ation of the tracheal and bronchoalveolar lavage fluid
(cytology, bacteriology and virology). We also investi-
gated whether lower airway inflammation would be in-
duced by the biopsy sampling procedure. Daily physical
examinations were performed as well as lower airway en-
doscopy including tracheal washes and broncho-alveolar
lavages on day 0 (prior to biopsy sampling) as well as 2
and 8 days after biopsy sampling. All vital parameters
remained normal in all horses. None of the horses
developed a cough or abnormal mucus secretion. The
cytology results of the tracheal washes and broncho-
alveolar lavages remained normal in all horses (data not
shown). During lower airway endoscopy, we did not ob-
serve any local inflammation (reddening, swelling) at the
biopsy sites; whereas a fast healing process was detected.
On day 8, it was often not possible to identify the biopsy
site anymore.
Once the EBEC culture conditions had been defined,
eight healthy untrained (UT) Standardbred horses (5
mares and 3 geldings, 2.5 ± 0.5 years, 450 ± 45 kg) were
enrolled for the second part of our study. All horses
were determined to be healthy by physical examination,
complete blood cell count, serum biochemistry, endo-
scopic evaluation of the respiratory tract and examin-
ation of the tracheal and bronchoalveolar lavage fluid
(cytology, bacteriology and virology). The horses had
been vaccinated (equine herpesvirus 1 and 4, equine in-
fluenza, tetanus) and dewormed and were kept in a
grass pasture prior to starting the study. During the
training period, the horses were stabled individually in
well-ventilated stalls on wood shavings. They were fed
grass silage and grain. In addition, they had daily access
to a large paddock for a minimum of 4 h.
Our protocols were approved by the Animal Ethics
Committee of the National Veterinary School of Alfort
(agreement number: 13/12/11-9) and the Animal Ethics
Committee of the University of Liege (agreement number:
13–1510).
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Prior to the start of the study, the horses were kept in a
grass pasture for 3 months (untrained = UT). This period
allowed the horses to get accustomed to the environment.
The horses started with 8 weeks of moderate training
(MT), meaning they were exercised on a sand track three
times a week. Each training session consisted of a six mi-
nute warm-up at 5.5 m/s, then trotting at progressively in-
creasing speeds (7.0 to 9.7 m/s) for 20 min, followed by a
recovery period of 3 min at 5.5 m/s. This was followed by
the intensive training (IT) period of 8 weeks. They were
exercised five times a week. Three sessions per week were
performed as during the moderate training period at grad-
ually increasing speeds up to their individual maximum
speeds for 20 min. Two sessions per week consisted of
interval (“sprint”) training at maximal speeds. During
these sessions, the horses underwent a warm-up of
15 min at 5.5 m/s, followed by 7 min at 7.0 m/s, then
during a period of 10 min the horses maintained speeds
of 9.7 to 11.0 m/s with the intercalated intervals (3 ×
90 s) at maximal speeds (11.0 to 13.4 m/s), finishing
with a recovery period of 3 min at 5.5 m/s. Heart rates,
distance and speed were monitored continuously dur-
ing each training session using a GPS on-board system
(Equine CS600X Trotting, Polar Electro France SAS).
Standardized exercise test (SET)
The horses underwent a SET on a treadmill until fatigue
prior to and at the end of the training period. The SET
was performed as previously published [9]. A fourth step
was performed at 11.0 m/s until fatigue.
Reagents
All reagents were purchased from Life Technologies,
Paisley, UK unless otherwise stated.
Sample collection
The horses were sedated with detomidine (0.002 mg/kg)
and butorphanol (0.005 mg/kg). Lower airway endoscopy
was performed (Karl Storz, Utrecht, Netherlands). Bron-
chial biopsies (2 × 2 mm) were collected between the 1st
and 3rd generation bronchi with biopsy forceps (Pentax,
Aartselaar, Belgium). The bronchial biopsies were placed
in cold DMEM/F-12 medium (Lonza, Verviers, Belgium)
supplemented with penicillin (100 IU/mL), streptomycin
(100 μg/mL) and amphotericin (0.25 μg/mL). The sam-
ples were kept at 4 °C and processed for cell culture
within 2 h of collection. Concurrently, bronchial biopsies
were placed in RNAlater® and stored at −20 °C until ana-
lysis for TLR and cytokine mRNA expression.
In the second part of the study, bronchial biopsies
were collected at rest (48 h prior to the SET) between
the 1st and 3rd generation bronchi of the left lung and
post-exercise (24 h after the SET) between the 1st and3rd bronchi of the right lung from horses in the un-
trained and trained condition.
Cell culture
In preliminary experiments, we tested a number of differ-
ent culture conditions in order to identify optimal culture
conditions for EBEC. Tissue culture plates were coated
with human placental collagen type I, human placental
collagen type IV (Sigma-Aldrich, St. Louis, MO, USA), calf
skin collagen G (Biochrom, Merck Millipore, Darmstadt,
Germany) as well as a mix of human fibronectin with bo-
vine serum albumin (BSA) (Merck Millipore, Darmstadt,
Germany) and collagens. We also used different culture
media: BEGM (Promocell, Heidelberg, Germany), LHC-8
medium, DMEM/F-12 with 2% ultroser, a mix of LHC-8
and DMEM/F-12, a mix of BEGM and DMEM/F-12, with
and without growth factors (epithelial growth factor, bo-
vine pituitary extract).
After collection, the bronchial biopsies were washed
three times in DMEM/F-12 medium. The biopsies were
then placed on coated tissue culture plates (6-well plates,
NUNC, Thermo Fisher Scientific, Erembodegem-Aalst,
Belgium) in a minimal volume of medium supplemented
with penicillin (100 IU/mL), streptomycin (100 μg/mL)
and amphotericin (0.25 μg/mL) and placed in the incu-
bator at 37 °C with 5% CO2 for 24–48 h in order to
favor the adherence of the biopsy. For the second part of
the study, bronchial biopsies were placed on collagen IV
coated plates in DMEM/F-12 medium supplemented with
2% ultroser (Pall Life Science, Cergy-Saint-Christophe,
France), penicillin (100 IU/mL), streptomycin (100 μg/
mL) and amphotericin (0.25 μg/mL). The medium was
changed every 2 to 3 days until the cell cultures reached
confluency (three to four weeks). The epithelial cell cul-
tures were assessed daily under the light microscope for
confirmation of their growth pattern (polygonal shape),
and to rule out possible contamination with fibroblasts.
We obtained 5 × 105 to 1 × 106 cells from a single explant.
Once cultures were confluent, the EBEC were detached
with trypsin, placed into DMEM/F-12 medium with 10%
fetal bovine serum (FBS; Fisher Scientific, Aalst, Belgium),
penicillin (100 IU/mL), streptomycin (100 μg/mL) and
amphotericin (0.25 μg/mL). The cells were centrifuged,
placed in DMEM/F-12 medium with 2% ultroser and then
transferred into 24-well tissue culture plates (1 × 105 cells
per well) for cell proliferation and subsequent stimulation
with TLR ligands. One aliquot of 1 × 105 EBEC was used
for flow cytometry systematically at each passage of cells
from each horse. Once confluency was reached again
(five to seven days), EBEC were stimulated with TLR2/6,
TLR3, TLR4, TLR7/8 and TLR9 ligands (FSL- 100 ng/mL;
Poly(I;C)- 50 μg/mL (CAYLA, Toulouse, France); LPS-
100 ng/mL (Sigma-Aldrich, Saint-Louis, MO, USA);
Gardiquimod- 1 μg/mL (CAYLA, Toulouse, France);
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class B CpG, Hycult Biotech, Uden, Netherlands), re-
spectively. Systematically, EBEC from one well of non-
stimulated cells were used for flow cytometry and EBEC
from a second well of non-stimulated and stimulated
cells were placed in Trizol® for the assessment of TLR
mRNA expression. Only cells from the first passage,
that were confirmed to be epithelial cells of excellent
purity (at least 95% cytokeratin positive and negative
for vimentin), were used for the evaluation of TLR
mRNA expression, TLR stimulation and the recovery of
supernatants for cytokine secretion.
Primary fibroblasts were grown from deeper bronchial
biopsy tissue. They had an accelerated growth rate and
reached confluency within 7–10 days.
Light microscopy
The primary EBEC and fibroblast cultures were moni-
tored daily under a phase contrast inverted microscope
(Olympus, Tokyo, Japan). The morphology of the EBEC
was documented and fibroblast contamination of the
EBEC cultures was ruled out.
Flow cytometry
To confirm the EBEC epithelial character, EBEC were
assessed systematically during their transfer (first passage)
and at the time of stimulation with TLR ligands. EBEC
were labeled with anti-cytokeratin antibodies (mouse
anti-human cytokeratin, clone MNF116, Dako, Hamburg,
Germany). Anti-vimentin antibodies (mouse anti-bovine
vimentin, clone Vim3B4, Dako, Hamburg, Germany) were
used to confirm the absence of fibroblast contamination.
Donkey anti-mouse IgG labeled with Alexa Fluor® 488 dye
were used as secondary antibodies.
Once confluent, EBEC were detached from tissue cul-
ture plates with trypsin, placed in DMEM/F-12 medium
with 10% FBS and cytocentrifuged. The cells were fixed in
1% formaldehyde, washed twice in 0.1% saponin to allow
for cell permeabilization and then incubated with anti-
cytokeratin or anti-vimentin antibodies for 30 min at 4 °C.
The cells were again washed in 0.1% saponin and were in-
cubated with the secondary antibodies for 30 min at 4 °C.
Then they were washed twice in PBS and placed in 0.25%
formaldehyde solution and analyzed within 24 h. Flow
cytometry analysis was performed on a BD Flowcytometer
(BD FACSCanto II, BD Biosciences, Erembodegem,
Belgium). In all conditions, negative controls were pre-
pared by omitting primary antibodies. The primary fibro-
blasts were stained with the same antibodies in order to
confirm their mesenchymal origin.
Cytokine measurement by ELISA
Cell culture supernatants were assayed for TNF-α (R&D
Systems, Abingdon, UK), IFN-β, IL-6 (USCN Life ScienceInc., Wuhan, China) and CXCL8 (Kingfisher Biotech Inc.,
Breda, Netherlands) concentrations with commercially
available equine ELISA kits.Muscle tissue
Microbiopsies of the gluteus medius muscle were obtained
as previously described [28]. This tissue served as calibra-
tor/control tissue for the TLR expression as previously de-
scribed [28] since muscle tissue is known to have the
lowest TLR expression within the body tissues [29].RNA isolation, cDNA synthesis and real-time PCR
RNA was isolated from bronchial biopsies, muscle biop-
sies and cultured EBEC with Trizol® reagent as described
by the manufacturer. Contaminating DNA was eliminated
using the Turbo DNA-free kit™. Concentration and
quality of RNA were assessed by UV spectrophotometry
(Nanodrop® ND2000, Thermo Fisher Scientific, Aalst,
Belgium) and a 2100 Bioanalyzer (Agilent Technologies,
Waldbronn, Germany). UV spectrophotometry allowed
the determination of the ratio of absorbance at 260 nm
and 280 nm. This ratio is used to assess the purity of
RNA. A ratio of 1.8-2.0 was accepted as indication of
“good quality” RNA. The quality of the RNA was fur-
ther assessed by a 2100 Bioanalyzer. Only RNA samples
with an RNA integrity number (RIN) ≥ 9 and a 28S:18S
ratio of > 2:1 qualified as “good quality” RNA and were
used for real-time PCR. cDNA were generated as previ-
ously described [28]. Gene expression of TLR1-9, fibro-
blast growth factor-1 (FGF-1), fibroblast specific protein-1
(FSP-1), E-cadherin, keratin19, IFN-β, TNF-α, IL-6 and
CXCL8 was quantified by real-time PCR using Absolute
Blue qPCR SYBR Green Mix (Fisher Scientific, Aalst,
Belgium) on an Applied Biosystems 7900 HT thermocy-
cler (Applied Biosystems, Carlsbad, CA, USA). Equine
gene specific primers were designed from available pub-
lished sequences [13,26,30,31] or designed in silico
(Table 1). Specificity of PCR was confirmed by melting
curve analysis, agarose gel electrophoresis and the ab-
sence of signals in RT minus RT reactions. All primers
designed for this study were located in single exons ex-
cept the primer for CXCL8 (2 separate exons). The ab-
sence of signals in RT minus RT reactions and the fact
that all primers, except for one, were located in single
exons confirm the absence of DNA contamination.
Real-time quantitative PCR data for TLR1-9, FGF-1,
FSP-1, E-cadherin, keratin19, IFN-β, TNF-α, IL-6 and
CXCL8 were normalized to the geometric mean of
three housekeeping genes (PGK1 (phosphoglyceroki-
nase 1), PPIA (cyclophilin A), RPL0 (ribosomal protein
L0)) using qbase + software (Biogazelle, Zwijnaarde,
Belgium). Muscle tissue was used as a calibrator for the
characterization of TLR mRNA expression in bronchial
Table 1 Primer sequences used for real-time PCR analysis of mRNA expression of target and housekeeping genes
Name Primer sequences forward/reverse (5′ to 3′) Product (bp) Exon Reference
PGK1 CGTCAAAGACCTGATGTCCA 98 1 In silico designed
TCTTGGCATGCTCATCAAAC
PPIA TGGGGAGAAATTTGATGATGA 116 1 In silico designed
TGGCAGTGCAGATGAAGAAC
RPL0 CCAAGGTTGAAGCAAAGGAA 99 1 [13]
AAAGCTGGCTGAATTGGTTG
FGF-1 AGAAGAATGGGAGCTGCAAA 138 1 In silico designed
GGACTCCTTCAGGCTCCTCT
FSP-1 GCCCTGGATGTGATGGTATC 93 1 In silico designed
CAGCAGCTCCTTTAGCTCTGA
E-cadherin ATCCGCAGCCTCATATCATC 125 1 In silico designed
CCCACCTGGGTCATTGTACT
Keratin19 GAAGGAGACCATGCAGAACC 120 1 In silico designed
CCCTGCTTCAGGTACCAGTC
IFN-beta CCCCGAGGACACAATGAACT 81 1 In silico designed
ACCAATGCAGCATCCTCCTT
TNF-alpha AAGGACATCATGAGCACTGAA 80 1 In silico designed
GGGCCCCCTGCCTTCT
IL-6 CCTGGTGATGGCTACTGCTT 102 1 In silico designed
TGCTGTTTGGTTTTGTCTGC
CXCL8 TTGGCCGTCTTCCTGCTTT 101 2 Intron (959 bp) In silico designed
GGTTTGGAGTGCGTCTTGATG
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the calibrator samples to derive the relative quantities.
Statistical analysis
TNF-α, IFN-β, IL-6 and CXCL8 concentrations as well
as relative gene expression data were analyzed by a glo-
bal linear mixed model (SAS, Cary, NC, USA). A general
linear mixed model was used for data analysis because it
combines a random effect (horses) and fixed effects
(training, strenuous exercise, treatment with TLR li-
gands). The mixed model allows considering the random
nature of the horses sample and accordingly, correcting
for potential individual differences, while modeling the
other (fixed) effects of interest in our study. In such a
multifactorial and unbalanced design, results were re-
ported as least square means (LSmeans) ± associated SE
instead of simple means in order to correct each factor
for possible contamination due to the other factors of
the model. Differences were considered to be significant
when p value was less than 0.05.
Results
Growth and characterization of EBEC in vitro
Homogenous cell populations consisting of non-ciliated
EBEC were cultured successfully using an explant method.Our preliminary tests showed that the EBEC grew better
on collagen IV coated plates in DMEM/F-12 medium with
2% ultroser (Table 2). The supplementation with growth
factors had no effect on the growth of EBEC in our model.
The cells had a polygonal shape which is typical for the
morphology of epithelial cells (Figure 1A). The epithelial
cell character was confirmed by positive staining for cyto-
keratin (Figure 1D) during each step of the EBEC culture
(passage of EBEC and at time of stimulation) and during
each phase of the study (untrained and trained horses).
Fibroblast contamination represents a common problem
in epithelial cell culture. Our data revealed that EBEC are
negative for vimentin in comparison with cultures of
fibroblasts (Figure 1D). Fibroblasts strongly expressed
mRNA encoding for FGF-1 and FSP-1, whereas these
mRNA were expressed about 100–1000 times less in
EBEC (Figure 1B). In contrast, EBEC strongly expressed
E-cadherin and keratin19 (Figure 1C). The EBEC pheno-
type was further confirmed by TLR mRNA expression,
particularly of TLR3 (as discussed in the following para-
graph). Figure 2 shows that EBEC have a similar pattern
of TLR mRNA expression as the bronchial epithelial bi-
opsy tissue itself. Furthermore, we show that the TLR
mRNA expression was neither altered by our culture tech-
nique (Figure 2) nor by training of the horses (Figure 3B).
Table 2 Comparison of different cell culture conditions for the in vitro culture of EBEC
Matrix coating medium Collagen I Collagen IV Collagen I +
collagen IV
Collagen G Fibronectin + BSA +
collagen I
Fibronectin + BSA +
collagen IV
BEGM (+) (+) (+) (+) - -
LHC-8 +(+) ++ + + - -
DMEM/F12 + 2% Ultroser +(+) +++ ++ +(+) - -
DMEM/F12 + 10% FBS - - - - - -
50% BEGM +50% DMEM/F12 + + + + - -
50% LHC-8 + 50% DMEM/F12 + (+) + (+) - -





Figure 1 Characterization of equine bronchial epithelial cells (EBEC). (A) Morphological appearance of EBEC cultures 7 days after plating
(phase contrast microscopy; objective magnification: x4). The biopsy is situated on the left bottom corner of the image. The biopsy is surrounded
by growing EBEC. Note the polygonal shape of EBEC. (B) Relative mRNA expression of Fibroblast growth factor-1 (FGF-1) and Fibroblast specific
protein-1 (FSP-1) in EBEC and fibroblasts. Significant differences (P < 0.05) in mRNA expression are identified with * for differences between EBEC
and fibroblasts. (C) Relative mRNA expression of E-cadherin and Keratin19 in EBEC and fibroblasts. Significant differences (P < 0.05) in mRNA expression
are identified with * for differences between EBEC and fibroblasts. (D) Flow cytometry analysis of in vitro cultured EBEC and fibroblasts for the epithelial
cell marker cytokeratin and the mesenchymal cell marker vimentin. (C-D) EBEC were assessed at their first passage (4–6 weeks of culture). Fibroblasts
were assessed at their first passage (7–10 days of culture). The phenotype and purity of EBEC were maintained during the study.
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Figure 2 Relative mRNA expression of TLR1-9 in bronchial biopsies (A) and EBEC (B). Muscle tissue is used as a calibrator for TLR mRNA
expression (muscle tissue = 1). Note that the profile of mRNA expression of TLR1-9 in bronchial biopsies and EBEC is similar, although the magnitude of
TLR mRNA expression is amplified after in vitro culture of 4–6 weeks duration (first passage).
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purity, and that their phenotype was maintained during
the study.
TLR expression in bronchial biopsies and in cultures of
EBEC
To estimate the relevance of our culture model, we com-
pared the expression of TLR in bronchial biopsies and
EBEC. As previously described in EBEC [32,33], TLR3
was the most strongly expressed TLR at the mRNA level
in bronchial biopsies (Figure 2A) as well as in EBEC cul-
tured in vitro (Figure 2B), followed by TLR2, TLR5 and
TLR1. However, the magnitude of TLR mRNA expres-
sion was amplified during in vitro culture. In both types
of samples, the expression of TLR4, TLR6, TLR7 and
TLR9 was low and nearly undetectable. Thus, weFigure 3 Relative mRNA expression of TLR1-9 and four cytokines in b
horses. The relative mRNA expression of TLR1-9 (A,B) and four cytokines (IFN
(A,C) and in non-stimulated cultures of EBEC (B,D) obtained from biopsies co
exercise (PE = post-exercise). No significant differences were observed.conclude that the pattern of TLR mRNA expression was
similar between bronchial biopsies and EBEC.
Cytokine mRNA expression in EBEC stimulated in vitro
with TLR ligands
To analyze the responsiveness of EBEC, we evaluated the
cytokine production after stimulation with TLR ligands.
The IFN-β mRNA expression was significantly increased
only by treatment with Poly(I:C), a TLR3 ligand, after
3 (P < 0.0001) and 6 (P < 0.005) hours of incubation
(Figure 4A). Treatment of EBEC with FSL (P < 0.0003),
LPS (P < 0.035) and Poly(I:C) (P < 0.0004) induced a
significant increase in mRNA expression of TNF-α
(Figure 4B) after 3 hours of incubation. The mRNA ex-
pression of IL-6 (Figure 4C) and CXCL8 (Figure 4D) was
significantly upregulated after 3 and 6 h of incubationronchial biopsies and cultured EBEC from untrained and trained
-β, TNF-α, IL-6, CXCL8) (C,D) was evaluated directly in bronchial biopsies
llected from untrained and trained horses, at rest as well as after an acute
(A) (B)
(C) (D)
Figure 4 Relative mRNA expression of IFN-β, TNF-α, IL-6 and CXCL8 after stimulation of EBEC with TLR ligands. EBEC were stimulated
with FSL, Poly(I:C), LPS, Gardiquimod and CpG. The mRNA expression of IFN-β (A), TNF-α (B), IL-6 (C) and CXCL8 (D) was evaluated after 3 and
6 h of incubation. Significant differences (P < 0.05) in mRNA expression are identified with * for differences between non-stimulated cells (NC) and
cells stimulated with TLR ligands.
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P < 0.0001), Poly(I:C) (P < 0.0001; P < 0.0006) and LPS
(P < 0.02; P < 0.0013). Treatment of EBEC with Gardiqui-
mod and CpG did not induce the mRNA expression of
these cytokines (Figures 4A-D). While Gardiquimod and
CpG represent appropriate TLR7/8 and TLR9 ligands, we
conclude that the low expression of TLR7/8 and TLR9 in
EBEC accounts for the non-responsiveness of EBEC to
these ligands.Cytokine production in EBEC stimulated in vitro with TLR
ligands
Because the mRNA expression of cytokines is sometimes
not correlated with the protein secretion in certain cells,
we decided to examine the cytokine production in
EBEC. Since the peak in cytokine mRNA expression was
observed after 3 h of incubation, the cytokine produc-
tion was measured after 6 h of stimulation. As previ-
ously reported [34], non-stimulated EBEC produced
almost non-detectable levels of IFN-β, TNF-α and IL-6
but had an important baseline secretion of CXCL8
(Figures 5A-D). Only stimulation with Poly(I:C) signifi-
cantly increased the production of IFN-β (P < 0.0001)
(Figure 5A) and IL-6 (P < 0.0001) (Figure 5C). TNF-α se-
cretion (Figure 5B) was significantly induced by treatment
with FSL (P < 0.0003) and Poly(I:C) (P < 0.0001). CXCL8secretion was significantly amplified by stimulation of
EBEC with FSL (P < 0.0001), Poly(I:C) (P < 0.0005) and
LPS (P < 0.0005) (Figure 5D). Treatment with Gardiqui-
mod and CpG had no or limited effects on cytokine secre-
tion (Figures 5A-D).
Since EBEC express low or undetectable levels of TLR7/
8 and TLR9 and they did not respond to stimulation with
a TLR7/8-ligand (Gardiquimod) or TLR9-ligand (CpG),
for the second part of the study we focused on TLR2/6,
TLR3, TLR4 in order to account for the most common re-
spiratory pathogens in horses [13].Training has no effect on TLR or cytokine mRNA
expression in bronchial biopsies and non-stimulated EBEC
The TLR mRNA expression was examined directly in
bronchial biopsy tissue and in non-stimulated EBEC cul-
tured in vitro. Training or acute strenuous exercise had
no effect on the TLR mRNA expression in either of them
(Figure 3A and B). We also evaluated cytokine mRNA
expression directly in bronchial biopsies and in non-
stimulated EBEC in order to assess if training or acute
exercise had an immediate effect on the baseline cyto-
kine mRNA expression. No significant differences were
observed after training or acute strenuous exercise re-
garding the mRNA expression of IFN-β, TNF-α, IL-6 or
CXCL8 (Figure 3C and D).
(A) (B)
(C) (D)
Figure 5 Production of IFN-β, TNF-α, IL-6 and CXCL8 after stimulation of EBEC with TLR ligands. EBEC were stimulated with FSL, Poly(I:C),
LPS, Gardiquimod and CpG. The protein secretion of IFN-β (A), TNF-α (B), IL-6 (C) and CXCL8 (D) after 6 h incubation of EBEC in medium alone
(NC) and after treatment with TLR ligands (FSL, Poly(I:C), LPS, Gardiquimod, CpG). Significant differences (P < 0.05) are identified with * for differences
between non-treated cells (NC) and cells treated with TLR ligands.
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In order to assess the effect of training and/or acute exer-
cise on the innate immune response, the cultured EBEC
were treated with TLR2/6, TLR3 and TLR4 agonists. EBEC
collected after an acute exercise responded to TLR ligands
in a similar manner as the controls (Figures 6A-D). In
contrast, the EBEC obtained from trained horses showed
an increased secretion of IFN-β (P < 0.0003) (Figure 6A)
and a lower production of TNF-α and IL-6 after treatment
with FSL (P < 0.05; P < 0.05) and Poly(I:C) (P < 0.0003; P <
0.01) (Figure 6B and C). The TNF-α secretion of FSL- and
Poly(I:C)-stimulated EBEC from trained horses after an
acute exercise was restored to a level similar to untrained
horses, whereas the IL-6 production was still strongly de-
creased (Figure 6C). The response to LPS for IL-6 and
CXCL8 was not modified. Training and acute exercise had
no effect on the CXCL8 secretion induced by TLR ligands
(Figure 6D).
Discussion
We report the successful culture of EBEC in vitro from
bronchial biopsies obtained in live horses. Our model al-
lows us to culture EBEC from small biopsies obtained
from the bronchial epithelium. EBEC do not cause any
lower airway inflammation and do not present a risk for
the horses. The in vitro cultured EBEC are responsive to
TLR activation, therefore, they facilitate the investigationof pathophysiologic conditions in longitudinal studies as
described in this work.
Previously, other authors have reported the successful
culture of airway epithelial cells in horses [21-26]. The use
of FBS in their culture medium was described and ap-
peared to favor tight junction formation in their studies
[25]. As shown by others [35-39], we found that FBS in-
creased the contamination of EBEC cultures with fibro-
blasts, accelerated fibroblast growth and indirectly limited
EBEC growth. Specific epithelial cell culture media are
commonly used in human and veterinary research and
were tested in our study. These defined media as well as
specific growth factors did not support the growth of
EBEC in our conditions. We hypothesize that the growth
of EBEC from bronchial biopsies is even more fragile and
sensitive than primary cell culture of airway epithelial cells
recovered by digestion of bronchial epithelial tissue in
which case large quantities of cells are made available. We
show that DMEM/F-12 medium supplemented with a
serum substitute (Ultroser G®) appeared to be the most
appropriate medium for the culture of EBEC as we previ-
ously described in human BEC [20]. In this condition, we
detected no detectable contamination by fibroblasts in our
cultures. Moreover, the phenotype and cell purity were
maintained during the culture as confirmed in a previous
report using the same methodology in clinical immun-
ology [20].
As expected, TLR3 was the most importantly expressed
TLR at the mRNA level in EBEC, followed by TLR2,
(A) (B)
(C) (D)
Figure 6 Ex vivo production of IFN-β, TNF-α, IL-6 and CXCL8 in EBEC from untrained and trained horses. EBEC were obtained from
biopsies collected from untrained and trained horses, at rest as well as after an acute exercise (PE = post-effort). EBEC were cultured in vitro and
stimulated with FSL, Poly(I:C) and LPS. We report the secretion of IFN-β (A), TNF-α (B), IL-6 (C) and CXCL8 (D) after 6 h of incubation in EBEC in
medium alone (NC) and activated cells. Significant differences (P < 0.05) are identified with * for differences from EBEC in untrained horses.
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very low levels. TLR1-6 proved to be functional in our
study with Poly(I:C) being the most efficient stimuli as a
TLR3 agonist. These findings were in agreement with
other studies [32,33,40]. Previously, Quintana et al. [26]
described a model for the culture of equine respiratory
epithelial cells and examined the expression of TLR1-4
and TLR6-10 mRNA. They reported decreased mRNA ex-
pression of TLR8-10 after 4 weeks of in vitro culture. In
our model, the profile of TLR mRNA expression remained
similar in EBEC when compared to bronchial biopsies al-
though the magnitude of TLR mRNA expression was
amplified during in vitro culture. Nonetheless, TLR3 was
still the most importantly expressed TLR (also with the
highest responsiveness) after several weeks of culture. The
stimulation of TLR3 activates the transcription factors
NF-кB and interferon regulatory factor 3 (IRF3) which
significantly increase IFN-β, TNF-α, IL-6 and CXCL8 pro-
duction confirming the importance of EBEC in the anti-
viral defense mechanisms of the lung [41]. Type-I IFN will
inhibit viral replication, whereas the proinflammatory cy-
tokines (TNF-α, IL-6) and chemokines (CXCL8) play im-
portant roles in immune cell recruitment. The mRNA
expression of TLR4 appears to be lower in EBEC com-
pared to its expression in human bronchial epithelial cells
(HBEC) [32,33,40]. This could represent a protective
mechanism in EBEC since horses are continuously ex-
posed to large quantities of dust and organic particulates
(shavings, straw, hay) that contain endotoxin [21]. Never-
theless, LPS stimulation induced the secretion of IL-6 and
at a lower level TNF-α underlining the functionality ofTLR4. Furthermore, Ainsworth et al. reported an upregu-
lation of TLR4 in bronchial epithelial cells of horses with
recurrent airway obstruction (RAO) which renders them
more sensitive to such endotoxin exposure. We also re-
port that TLR7-9 are not functional in EBEC as confirmed
by the treatment with TLR7-9 agonists. This was in agree-
ment with previous publications in HBEC [33,34].
The effect of training and acute exercise on TLR-
associated airway epithelial cell function has not been re-
ported previously. Several researchers have examined the
effect of exercising in a cold environment on the airway
epithelium. Bronchial epithelial cell damage, apoptosis,
loss of ciliated epithelial cells and airway remodeling have
been described in sled dogs [42] and horses [43]. In this
study, neither training nor acute strenuous exercise had
an effect on the mRNA expression at baseline of TLR or
cytokines in bronchial biopsy tissue and EBEC. Our data
underline that even though some damage can be observed
in airway epithelium after exercise, this was not associated
with airway inflammation and modulation of TLR mRNA
expression. Only the exposure to TLR agonists, which
mimicked experimental bacterial/viral infection, revealed
altered EBEC function in cells from trained horses. Intense
training but not acute exercise impaired the secretion of
TNF-α and IL-6 only in response to FSL and Poly(I:C).
FSL mimics infection with gram + bacteria, whereas Poly
(I:C) mimics viral infection, thereby representing the
most common equine pulmonary pathogens. The down-
regulated production of pro-inflammatory cytokines could
be caused by secretion of anti-inflammatory cytokines
as suggested by others [44]. We did not evaluate anti-
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study, and therefore cannot argue their importance
here. The decreased TNF-α secretion might also suggest a
defect in cell recruitment by EBEC in trained horses.
TNF-α is one of the first cytokines produced after stimula-
tion with TLR ligands, exposure to pathogens or other ir-
ritants. It then stimulates the secretion of other cytokines
and chemokines (CCL2, CCL3) that result in the recruit-
ment of monocytes and their differentiation into dendritic
cells and tissue macrophages. This alteration in cell re-
cruitment might play an important role in limiting the
lung defense mechanism and therefore, represent an es-
sential mechanism in organ-specific regulation of immun-
ity [45,46]. In contrast, IFN-β production by EBEC was
increased after training. We recently described decreased
TLR3 mRNA expression and decreased IFN-β production
in equine PAM after training [13]. The increased IFN-β
secretion by EBEC might reflect a compensatory mechan-
ism for the low pulmonary IFN-β levels in trained horses.
Altogether, the decreased type I IFN and cytokine secre-
tion in the lung from trained horses might favor the devel-
opment of viral infection and thereby, might increase
secondary bacterial infection in the lung. As already men-
tioned in our previous work [13], our data show that the
type and the intensity of the exercise (acute exercise/train-
ing) as well as the environmental conditions play an im-
portant role in the innate immune defense.
In conclusion, we report a successful model for the
culture of EBEC in vitro that can be applied to the inves-
tigation of pathophysiologic conditions in longitudinal
studies. These EBEC present a profile of expression and
function of TLR similar to what we can find in bronchial
biopsies and in other cell culture models. Training al-
tered the IFN-β, TNF-α and IL-6 secretion in response
to TLR2 and TLR3 ligands in EBEC and, therefore, may
have important effects on immune cell recruitment in
exercising horses. Altogether, this mechanism may be
implicated in the increased risk for viral and bacterial in-
fections observed in sport horses.
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